Clinical Trials
Pharma development company completes phase II study of low estrogen contraceptive patch
Published in Women's Health Weekly, December 29th, 2005
Most contraceptive products contain both a progestin and estrogen and are associated with certain common side effects, such as breast tenderness, bloating/weight gain and nausea. These side effects are believed to be related to the level of hormones delivered into the blood stream, particularly with higher levels of estrogen.
In recent years, treatment trends have moved towards lower hormone exposure. The Agile patch is designed to deliver levonorgestrel and ethinyl...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Endometrioma
Excisional surgery exhibits outcomes benefit vs. ablative surgery for endometrioma - Hepatitis C Virus Transmission
Maternal transmission of hepatitis C virus is not influenced by cesarean section - Lactation
Role of compensatory mammary growth studied in epigenetic control of gene expression - Menopause
Perimenopause is reported to be a time of increased vulnerability to chronic disease - Stroke
Estrogens may play key role as multiple targeting protectants against ischemic stroke - Anxiety Disorders
Article reviews causes for heightened risk of anxiety disorders in women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
